Berger Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$487K Sell
2,312
-52
-2% -$10.4K 0.02% 312
2026
Q2
$450K Sell
2,364
-195
-8% -$33.5K 0.02% 311
2026
Q1
$432K Sell
2,559
-251
-9% -$42.9K 0.02% 306
2025
Q4
$474K Sell
2,810
-19
-0.7% -$3.09K 0.03% 302
2025
Q3
$408K Buy
2,829
+75
+3% +$10.2K 0.02% 308
2025
Q2
$348K Sell
2,754
-226
-8% -$27.7K 0.02% 317
2025
Q1
$381K Buy
2,980
+389
+15% +$52.7K 0.03% 296
2024
Q4
$343K Buy
+2,591
New +$364K 0.02% 307
2023
Q3
– Sell
-3,728
Closed -$473K – 284
2023
Q2
$473K Buy
3,728
+3
+0.1% +$390 0.05% 164
2023
Q1
$481K Hold
3,725
– – 0.06% 159
2022
Q4
$489K Hold
3,725
– – 0.06% 154
2022
Q3
$436K Sell
3,725
-8
-0.2% -$993 0.06% 152
2022
Q2
$439K Sell
3,733
-77
-2% -$9.14K 0.06% 149
2022
Q1
$496K Hold
3,810
– – 0.06% 149
2021
Q4
$581K Sell
3,810
-114
-3% -$17.6K 0.08% 138
2021
Q3
$634K Buy
3,924
+11
+0.3% +$1.85K 0.11% 98
2021
Q2
$640K Sell
3,913
-13
-0.3% -$2K 0.12% 97
2021
Q1
$591K Buy
3,926
+808
+26% +$128K 0.13% 97
2020
Q4
$472K Buy
+3,118
New +$446K 0.08% 131

Other funds holding IBB

Berger Financial Group's IBB Position: Q3 2026 in Review

Berger Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 2.2% in Q3 2026, selling an estimated $10.4K and leaving 2,312 shares worth $487K. The position accounts for 0.02% of the portfolio, ranked #312.

Berger Financial Group first reported a position in IBB in Q4 2020 and has held it in 19 quarters since. The position peaked at $640K in Q2 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Berger Financial Group held 2,312 shares of iShares Biotechnology ETF worth $487K as of Q3 2026.
  • Berger Financial Group sold 52 iShares Biotechnology ETF shares in Q3 2026, an estimated $10.4K.
  • iShares Biotechnology ETF made up 0.02% of Berger Financial Group's portfolio in Q3 2026, its #312 holding.
  • Berger Financial Group first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 19 quarters since.
  • Berger Financial Group's iShares Biotechnology ETF position peaked at $640K in Q2 2021.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Berger Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.